Micro-embolic Signals Detection With Transcranial HOLter in Acute Ischemic STroke
NCT: NCT02762552 · COMPLETED
Brief Summary
In acute ischemic stroke, the identification of an etiology is of major importance to prevent recurrence by providing the best treatment. Because of numerous possible underlying etiologies, the etiological work-up of ischemic stroke includes a wide range of diagnostic tests, which can be invasive, long and expensive. Moreover, many patients receive a diagnosis of undetermined stroke even after all available diagnosis tests are done, precluding optimal treatment.
Frequently Asked Questions
What is Micro-embolic Signals Detection With Transcranial HOLter in Acute Ischemic STroke?
Micro-embolic Signals Detection With Transcranial HOLter in Acute Ischemic STroke is a clinical trial registered under NCT02762552. Current status: COMPLETED.
What is the status of NCT02762552?
The current status of NCT02762552 (Micro-embolic Signals Detection With Transcranial HOLter in Acute Ischemic STroke) is: COMPLETED.
When did Micro-embolic Signals Detection With Transcranial HOLter in Acute Ischemic STroke start?
Micro-embolic Signals Detection With Transcranial HOLter in Acute Ischemic STroke started on 2015-09-14.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.